| miRNA: a promising therapeutic target in cancer A Menon, N Abd-Aziz, K Khalid, CL Poh, R Naidu International journal of molecular sciences 23 (19), 11502, 2022 | 117 | 2022 |
| The promising potential of reverse vaccinology-based next-generation vaccine development over conventional vaccines against antibiotic-resistant bacteria K Khalid, CL Poh Vaccines 11 (7), 1264, 2023 | 17 | 2023 |
| Identification of B-cell epitopes for eliciting neutralizing antibodies against the SARS-CoV-2 spike protein through bioinformatics and monoclonal antibody targeting HX Lim, M Masomian, K Khalid, AU Kumar, PA MacAry, CL Poh International Journal of Molecular Sciences 23 (8), 4341, 2022 | 15 | 2022 |
| The development of DNA vaccines against SARS-CoV-2 K Khalid, CL Poh Advances in Medical Sciences 68 (2), 213-226, 2023 | 9 | 2023 |
| Development of next generation vaccines against SARS-CoV-2 and variants of concern AA Al-Fattah Yahaya, K Khalid, HX Lim, CL Poh Viruses 15 (3), 624, 2023 | 6 | 2023 |
| Preclinical Development of a Novel Epitope-based DNA Vaccine Candidate against SARS-CoV-2 and Evaluation of Immunogenicity in BALB/c Mice K Khalid, HX Lim, A Anwar, SH Tan, JS Hwang, SK Ong, CL Poh AAPS PharmSciTech 25 (3), 60, 2024 | | 2024 |
| Probiotics: A solution to the prevention of antimicrobial resistance CL Poh, K Khalid, HX Lim Antibiotics-Therapeutic Spectrum and Limitations, 595-609, 2023 | | 2023 |
